Therapy Areas: Diabetes
Mölnlycke acquires patent to detect infected wounds
6 June 2019 -

Swedish medical solutions company Mölnlycke said on Wednesday that it plans to acquire a patent that will help detect infections in wounds.

Under the terms of the agreement, Mölnlycke has agreed to acquire the patent from Swedish regional innovation company, Innovation Skåne.

Skåne's technology can detect infections and alert caregivers that the wound needs attention. It will help to minimise the prophylactic use of antibiotics and reduce the risk of complications related to infections. Once developed, the patent will play a major role in reducing the unnecessary use of antibiotics in wound care.

According to the companies, the incidence of infection in hard-to-heal chronic wounds, such as diabetic foot ulcers and venous leg ulcers, is high and one in 20 patients undergoing surgery will develop a surgical site infection. However, infected wounds are costly, difficult to manage and hard to detect. In many cases, expensive antimicrobials are used prophylactically to prevent infections or to treat them once they have been established.

Login
Username:

Password: